# Real-world outcomes in patients with metastatic castration-resistant prostate cancer receiving second-line chemotherapy versus an alternative androgen receptor-targeted agent (ARTA) following early progression on a first-line ARTA in a US community oncology setting

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/real-world-outcomes-in-patients-with-metastatic-castration-resistant-prostate/

## Facts

| Field | Value |
| --- | --- |
| Author Names | William Oh,Wendy Y. Cheng,Raymond Miao,Francis Vekeman,Marjolaine Gauthier‐Loiselle,Mei Sheng Duh,Edward J. Drea,Ted P. Szatrowski |
| Citations | 57 |
| DOI | 10.1016/j.urolonc.2018.08.002 |
| Fields | Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://www.sciencedirect.com/science/article/pii/S1078143918302965/pdf |
| OpenAlex ID | https://openalex.org/W2890158717 |
| PMID | 30201382 |
| Type | article |
| Year | 2018 |

## Paper authors

- [Marjolaine Gauthier‐Loiselle](https://scholariq.org/researchers/marjolaine-gauthier-loiselle/)

## Paper primary topic

- [Prostate Cancer Treatment and Research](https://scholariq.org/topics/prostate-cancer-treatment-and-research/)

## Paper topics

- [Prostate Cancer Treatment and Research](https://scholariq.org/topics/prostate-cancer-treatment-and-research/)
- [Prostate Cancer Diagnosis and Treatment](https://scholariq.org/topics/prostate-cancer-diagnosis-and-treatment/)
- [Radiopharmaceutical Chemistry and Applications](https://scholariq.org/topics/radiopharmaceutical-chemistry-and-applications/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.